Single femoral artery access is safe and feasible during transcatheter aortic valve replacement: a propensity score matched analysis

Author:

Yan Yunfeng,Yao Jing,Yuan Fei,Liu Xinmin,Luo Taiyang,Lu Zhinan,Chang Sanshuai,Zhang Qian,Liu Ran,Yin Chengqian,Song Guangyuan

Abstract

BackgroundTranscatheter aortic valve replacement (TAVR) potentially may be significantly simplified by using the single artery access (SA) technique, which does not require a secondary artery access. Nevertheless, the safety and efficacy of this technique remains unclear. Our goal was to determine if single artery access TAVR (without upgrading the sheath size) is a feasible, minimally invasive procedure.MethodsPatients with symptomatic severe aortic stenosis who underwent TAVR via the femoral artery were consecutively enrolled in this study. Eligible individuals were divided into 2 groups: the SA group and the dual artery access (DA) group. The primary end point was device success (defined by the valve academic research consortium 3, VARC 3). A 6-month follow-up and propensity score matching analyses were performed.ResultsAfter propensity score matching analysis, a total of 130 patients were included: 65 in the SA group and 65 in the DA group. The SA procedure achieved similar device success (95.4% vs. 87.7%; P = 0.115) compared with the DA procedure. The SA procedure shortened the operating time (102 min vs. 125 min; P = 0.001) but did not increase the x-ray time or dose. Both a 20 Fr and a 22 Fr sheath (without upgrading the sheath size) could be used for the SA procedure. There was no major vascular complication occurred in both groups. The incidence of minor main vascular and access complications in the SA group was comparable to those of the DA procedure (0.0% vs. 3.1%; P = 0.156).ConclusionsThe SA access procedure is a promising minimally invasive TAVR technique with a low incidence of vascular complications and a high incidence of device success. It is safe and possibly applicable in all TAVR procedures.

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description;Cribier;Circulation,2002

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Otto;J Am Coll Cardiol,2021

3. ESC/EACTS scientific document group. 2021 ESC/EACTS guidelines for the management of valvular heart disease;Vahanian;Eur Heart J,2022

4. Structural cardiology committee of cardiovascular physicians branch, Chinese medical doctor association, expert consensus on clinical pathway for transcatheter aortic valve replacement in China;Chinese J Interventional Cardiol,2022

5. Simplified TAVR procedure: how far is it possible to go?;Leclercq;J Clin Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3